Sangui Biotech International, Inc.
SGBI · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $3 | $30 | $30 |
| Short-Term Investments | – | $0 | $0 | $0 |
| Receivables | – | $27 | $13 | $25 |
| Inventory | – | $0 | -$0 | $0 |
| Other Curr. Assets | – | $12 | $12 | $12 |
| Total Curr. Assets | – | $42 | $68 | $67 |
| Property Plant & Equip (Net) | – | $49 | $63 | $67 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $0 | $0 | $0 |
| Long-Term Investments | – | $0 | $0 | $0 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | $0 | $0 | -$67 |
| Total NC Assets | – | $49 | $63 | $67 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $91 | $131 | $134 |
| Liabilities | – | – | – | – |
| Payables | – | $205 | $128 | $127 |
| Short-Term Debt | – | $766 | $735 | $777 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $0 | $0 | $0 |
| Other Curr. Liab. | – | $93 | $72 | $50 |
| Total Curr. Liab. | – | $1,064 | $936 | $955 |
| LT Debt | – | $65 | $90 | $55 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $0 | $0 | $0 |
| Total NC Liab. | – | $65 | $90 | $55 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $43 | $57 | $67 |
| Total Liabilities | – | $1,129 | $1,026 | $1,009 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $33,125 | $33,125 | $33,088 |
| Retained Earnings | – | -$38,102 | -$37,955 | -$37,895 |
| AOCI | – | $101 | $97 | $90 |
| Other Equity | – | $4,494 | $4,494 | $4,494 |
| Total Equity | – | -$382 | -$239 | -$224 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | -$656 | -$656 | -$652 |
| Total Liab. & Tot. Equity | – | $91 | $131 | $134 |
| Net Debt | $0 | $828 | $795 | $802 |